Abstracts

We encourage researchers and organizations to submit their data in relation to translating diagnostic- and therapy advances of viral hepatitis into broad applications that accelerate progress toward elimination of viral hepatitis as a public health threat by 2030.

Abstract submission for the International Viral Hepatitis Elimination meeting 2017 is now closed. However, if you have data that you feel is a vital addition to the meeting please contact the meeting secretariat


General guidelines
Abstracts should contain the following four components:

  • Background
    A concise statement of the issue under investigation or a hypothesis;
  • Material & Methods
    The experimental methods used (including the statistical analyses employed);
  • Results
    Specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
  • Conclusions
    A summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).

Please note that abstracts cannot be accepted if tables or graphs are included. The maximum word count for the abstract body is 500 words.

Abstracts are considered official communications to the conference and will be treated confidentially. Submitters of accepted abstracts agree to attend the meeting and present their abstract as scheduled. 


Abstract submission

Authors can submit their abstracts electronically until 17 September 2017 using the button on the right hand tab. This will direct you to the appropriate webpage. Please follow the step-by-step directions to upload the abstract. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.

Categories and topics for abstract submission 

For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category.

Topics:

  • Testing and screening strategies
  • Care and cure strategies
  • Prevention and screening strategies
  • Innovative models for elimination

Young Professionals 

We are pleased to offer free registration to young professionals with an accepted abstract and a discount on the registration fee for young professionals without an accepted abstract.

Free registrations/discounts are offered to:
- young professionals in training
- young professionals who have obtained an MD/PhD degree in the last five years

In order to receive a special registration code the young professional needs to ask a supervisor to complete the application form and send it to: michael@vironet.com prior to 6 November 2017.

IMPORTANT: free registration is offered to the presenting author of the abstract only.

Notification of abstract acceptance and presentation format 

Notifications of acceptance and format of presentation (oral or poster presentation) will be e-mailed to the submitting author. It is the responsibility of the corresponding/presenting author to inform all co-authors of the status of the abstract. Please notify the Conference Secretariat if you have not received notification by the second week of October. If your abstract is accepted, one author is required to register for the conference and present the paper as scheduled. Guidelines for preparing your oral and/or poster presentations will be sent after your abstract has been accepted.

Abstract publication 

Accepted abstracts will be published in the Abstract Book, which will be distributed during the conference. In addition, all abstracts will be published in the journal Reviews in Antiviral Therapy & Infectious Diseases. Please note that the conference secretariat cannot be held responsible for any typing or language errors in the submitted abstracts as only the format of the abstracts will be changed and not the content.